SRX Global is trading 6.2% lower at $1.51, with no confirmed catalyst explaining the pre-market drop. - This compares with the October 1 close of $1.61. - Its press-release page lists a September 24 announcement about portfolio liquidations and an Onconetix investment; no October 1 or October 2 release is shown. - The supplied context shows a firmer broad-market backdrop, so the decline cannot be attributed to a general market selloff; no sector or company catalyst was confirmed.